Cross Staff Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Hold
4,800
0.25% 85
2026
Q1
$409K Hold
4,800
0.21% 90
2025
Q4
$379K Hold
4,800
0.21% 92
2025
Q3
$384K Hold
4,800
0.27% 93
2025
Q2
$436K Hold
4,800
0.32% 84
2025
Q1
$450K Hold
4,800
0.34% 78
2024
Q4
$436K Hold
4,800
0.3% 79
2024
Q3
$498K Hold
4,800
0.38% 72
2024
Q2
$466K Hold
4,800
0.39% 67
2024
Q1
$432K Hold
4,800
0.36% 74
2023
Q4
$383K Hold
4,800
0.34% 82
2023
Q3
$341K Hold
4,800
0.33% 84
2023
Q2
$370K Hold
4,800
0.34% 86
2023
Q1
$361K Hold
4,800
0.36% 85
2022
Q4
$378K Hold
4,800
0.4% 81
2022
Q3
$337K Hold
4,800
0.38% 80
2022
Q2
$385K Hold
4,800
0.42% 76
2022
Q1
$364K Hold
4,800
0.34% 87
2021
Q4
$410K Buy
+4,800
New +$375K 0.37% 84

Other funds holding CL

Cross Staff Investments's CL Position: Q2 2026 in Review

Cross Staff Investments held its Colgate-Palmolive (CL) position steady in Q2 2026 at 4,800 shares worth $440K. The position accounts for 0.25% of the portfolio, ranked #85.

Cross Staff Investments first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $498K in Q3 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cross Staff Investments held 4,800 shares of Colgate-Palmolive worth $440K as of Q2 2026.
  • Cross Staff Investments left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.25% of Cross Staff Investments's portfolio in Q2 2026, its #85 holding.
  • Cross Staff Investments first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • Cross Staff Investments's Colgate-Palmolive position peaked at $498K in Q3 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.